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Heterotopic ossification (HO) is characterized by the formation of bone at atypical sites.
This type of ectopic bone formation is most prominent in skeletal muscle, most frequently
resulting as a consequence of physical trauma and associated with aberrant tissue
regeneration. The condition is debilitating, reducing a patient’s range of motion and
potentially causing severe pathologies resulting from nerve and vascular compression.
Despite efforts to understand the pathological processes governing HO, there remains
a lack of consensus regarding the micro-environmental conditions conducive to its
formation, and attempting to define the balance between muscle regeneration and
pathological ossification remains complex. The development of HO is thought to be
related to a complex interplay between factors released both locally and systemically
in response to trauma. It develops as skeletal muscle undergoes significant repair and
regeneration, and is likely to result from the misdirected differentiation of endogenous
or systemically derived progenitors in response to biochemical and/or environmental
cues. The process can be sequentially delineated by the presence of inflammation,
tissue breakdown, adipogenesis, hypoxia, neo-vasculogenesis, chondrogenesis and
ossification. However, exactly how each of these stages contributes to the formation
of HO is at present not well understood. Our previous review examined the cellular
contribution to HO. Therefore, the principal aim of this review will be to comprehensively
outline changes in the local tissue micro-environment following trauma, and identify how
these changes can alter the balance between skeletal muscle regeneration and ectopic
ossification. An understanding of the mechanisms governing this condition is required
for the development and advancement of HO prophylaxis and treatment, and may even
hold the key to unlocking novel methods for engineering hard tissues.
Keywords: heterotopic ossification, hypoxia-inducible factor 1, endochondral ossification, macrophage
polarization, bone morphogenetic proteins, vascular endothelial growth factors, satellite cells, skeletal muscle
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BACKGROUND
Heterotopic ossification (HO) is defined as the formation of
mature bone at atypical sites, such as skeletal muscle or tendon.
Patients with HO will experience a range of clinical problems
resulting from the formation of extra-skeletal hard tissue,
including pain, joint ankylosis, and neurovascular entrapment,
as well as problems with prosthetic limb fitting. Current
prophylaxis and treatments have varying levels of success and
include the use of non-steroidal anti-inflammatories (NSAIDs),
bisphosphonates, and single dose radiotherapy. A thorough
discussion of the benefits and drawbacks of these clinical
methods can be found in a previous review (Davies et al.,
2015). Currently, the underlyingmechanisms governing acquired
HO are not well understood, with the osteoinductive action
of certain BMPs, implicated in genetic forms of the condition,
such as fibrodysplasia ossificans progressiva (FOP), likely to be
only partly responsible. A prevailing view is that acquired HO
occurs as a consequence of aberrant muscle repair resulting
from a chronic inflammatory environment. Although, the exact
switch defining the balance between muscle repair and HO is
likely to be complex and multifaceted. This complexity arises
from the overall scale of the local and systemic response to
trauma, as well as the differential action of pro- and anti-
inflammatory cytokines on the heterogeneous population of
cells present at the trauma site. This includes cells of different
origins and states of commitment, such as endogenous skeletal
muscle cells and migratory multipotent progenitors, as well as
pericytes and endothelial cells derived from the local vasculature.
With this in mind, the aim of the review is to identify how
chronic inflammation can alter the balance between skeletal
muscle regeneration and pathological outcomes such as HO,
in particular detailing how inflammatory dysregulation may
contribute to the misdirected differentiation of cells localized
at the wound bed. We will also place this in context with the
current understanding of the sequential series of events leading
to the formation of HO to better understand this debilitating
phenomenon.
INFLAMMATION
Inflammation is known to play an important and multifaceted
role in directing cell recruitment, vascularization, and cartilage
remodeling during bone repair. Therefore, it has been
hypothesized that persistent inflammatory dysregulation
resulting from severe traumas such as military blast injuries
may negatively affect wound healing and be conducive to
extra-skeletal ossification in soft tissues (Hahm et al., 2011).
Physical injury triggers an inflammatory cascade, which is
characterized by the rapid and sequential invasion of leukocytes
that persists throughout muscle repair, regeneration and growth.
Studies detailing the inflammatory response of this tissue to
trauma have shown that the first inflammatory cells recruited
to the site of muscle injury are the neutrophils and T helper
cells (Th) (Loell and Lundberg, 2010). The primary role of these
cells is to remove tissue debris from the damaged area and
contribute to the activation of resident satellite cells to promote
muscle regeneration. The migration of neutrophils and Th is
followed by the sequential infiltration of other inflammatory
cell types, with macrophages dominating after approximately
24 h (McClung et al., 2007). The invasion of macrophages
functions to remove necrotic tissue, as well as facilitating
myoblast proliferation and differentiation to promote muscle
repair. However, macrophages are extremely plastic cells, with
previous studies showing that the exact function of these cells
is dependent on the local tissue environment (Novak et al.,
2015). Since severe traumas linked with HO (e.g., blast trauma
or traumatic brain injury) can cause unrecognizable damage to
local and surrounding tissues, this raises the question of how
macrophage plasticity influences the balance between skeletal
muscle repair and HO. At the most basic level macrophages
can be split into two subsets: M1 “pro-inflammatory” and
M2 “anti-inflammatory” cells, with the two subtypes having
distinct roles during tissue regeneration. In human muscle, M1
macrophages are predominantly associated with satellite cell
activation and proliferation, whereas M2 macrophages have
an increased presence during terminal myogenesis (Saclier
et al., 2013). Both subtypes are known to coexist in chronically
injured muscle, yet their effects on tissue repair and homeostasis
are negligible (Rigamonti et al., 2014). At present no studies
have comprehensively detailed the inflammatory events that
occur within chronic muscle wounds, with the majority of
research confined to models of mild/moderate trauma. As a
consequence, the temporal roles of M1 and M2 macrophages
in this process remain unclear, and the effects of inflammatory
events such as macrophage polarization on HO are not fully
understood (Figure 1). Advancing our current understanding
of the association between inflammatory dysregulation and
ectopic ossification will be of considerable benefit for identifying
novel prophylactics and treatments for both genetic and
acquired forms of HO, as well as for the formulation of new
regenerative therapies for bone tissue engineering. We shall
now direct our attention to the expanding number of proteomic
studies that have sought to profile cytokines within the post-
trauma environment, and the effects these cytokines may have
on HO.
It has long been established that severe injuries such as
blast trauma, traumatic brain injury (TBI) and spinal cord
injury (SCI) are linked with HO, and that factors present in
the local wound bed, eﬄuent, or released into the circulation
following these injuries may have positive relationship with
extra-skeletal ossification (Hawksworth et al., 2009). A popular
approach has been to proteomically analyse the wound site to
identify the roles that humoral factors have in the induction
or enrichment of the HO environment. Current proteomic
studies face several technical limitations principally concerning
the maximum resolution of a given technique or unstandardized
methods of sample preparation, as well as uncontrollable
variables such as the timing of sample acquisition, scale of
trauma, and the type of trauma (blast, TBI, SCI, burn etc.).
Nonetheless, despite these limitations such studies may prove
highly valuable and may be applied for the development
of much needed diagnostic tools. The development of such
tools may someday enable clinicians to provide a quantifiable
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FIGURE 1 | How inflammatory cytokines and subsequent macrophage polarization may influence skeletal muscle regeneration following traumatic
injury. Macrophage polarization coordinates the initial pro-inflammatory and subsequent regenerative/anti-inflammatory phases required for the removal of local
debris and the regeneration of tissue, respectively. Inflammatory dysregulation will alter the balance of these phases, compromising effective tissue repair and
potentially leading to tissue fibrosis and subsequent HO. Circular arrows indicate self-renewal.
prediction of a patient’s risk of developing HO, as well as
other negative outcomes associated with blast trauma such as
wound dehiscence (Forsberg et al., 2008). Current research
has identified that there are at least 14 proteins exclusive to
the serum of TBI patients that have a direct binding affinity
with human osteoprogenitors in vitro (Cadosch et al., 2009b).
However, full bioinformatic characterization of these proteins
is required before any conclusions can be made regarding their
effects on muscle regeneration and HO. Significantly, in several
rat models of induced TBI, proteomic analysis of the local serum
has identified many of the same cytokines and growth factors
present during fracture repair, such as TGF-β, insulin-like growth
factor (IGF), IL-1, IL-6 and BMPs (Pasinetti et al., 1993; Kim
et al., 1996; Jackson et al., 2012). A subsequent human study that
collected and analyzed the serum and wound exudate of victims
of penetrating combat-related traumas found increased levels of
a number of interleukins, as well as the presence of monocyte
chemoattractant protein-1 (MCP-1), interferon gamma-induced
protein 10 (IP-10) and macrophage inflammatory protein alpha
(MIP-α) (Evans et al., 2012). Many of the cytokines identified
in the local wound environment are well known inducers
of osteogenic differentiation in MSC cultures (Sidney et al.,
2014), and the up-regulation of humoral factors following TBI
has been shown to significantly enhance fracture healing and
callus formation in patients with long bone defects (Cadosch
et al., 2009a). Furthermore, osteogenic differentiation of MSCs
exposed to serum extracted from both humans and animals
following TBI has established a link between the body’s systemic
response to injury and HO (Cadosch et al., 2010). Therefore,
given the role of inflammatory factors during bone regeneration
and the osteoinductive effects of local and systemic factors
released in response to trauma on MSCs and skeletal muscle
cell differentiation, it seems reasonable to propose that these
factors may also play a significant role in the aberrant processes
underlying HO.
MUSCLE REPAIR AND OSSIFICATION
Skeletal muscle trauma and inflammation is accompanied by
the activation and migration of resident satellite cells, as
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FIGURE 2 | Prominent factors identified in proteomic and genomic profiling studies of post-trauma serum/exudate and their potential
osteochondrogenic effects on cells identified at the wound site. Dysregulation or prolonged exposure to these factors may prevent efficient wound healing and
instead facilitate tissue fibrosis and the osteochondrogenic differentiation of resident and/or migratory cell types. Dysregulation of these factors following traumatic
injuries has also been shown to promote the transdifferentiation of resident endothelial cells lining the tissues vasculature, with endothelial-mesenchymal transition
representing a well-established example of this phenomenon that has been linked with HO. The presence of a hyper-inflammatory environment may also induce
myoblast reversion to a less committed satellite or progenitor cell capable of osteogenic differentiation.
well as the breakdown and remodeling of soft tissue at the
site of injury. This process contributes to regeneration that
serves to replace damaged tissue at the wound site. Every
cycle of muscle regeneration leads to an increased deposition
of extracellular matrix, specifically interstitial collagen, which
is hypothesized to adversely affect regeneration and instead
lead to the deposition of fibrous and fatty replacement tissue
(Uezumi et al., 2014). It is currently unknown whether this
fibrous replacement tissue has a direct relationship with the
fibroproliferative lesions preceding HO. However, what is known
is that fibrosis becomes exaggerated in the presence of chronic
inflammation resulting as a consequence of severe trauma,
and that this process appears to be correlated with local
production of TGF-β (Mendias et al., 2012). In addition to
TGF-β, other prominent growth and inflammatory factors at
the site of regenerating skeletal muscle include fibroblast growth
factor (FGF), insulin-like growth factors (IGFs), hepatocyte
growth factor (HGF) and tumor necrosis factor-alpha (TNF-
α). These proteins are secreted by endogenous muscle cells
as well as infiltrating leukocytes such as macrophages and
neutrophils. Currently, details concerning the contribution of
the post-trauma inflammatory response to HO are limited.
However, significant attention has been paid to understanding
the contribution of persistent inflammatory dysregulation
to skeletal muscle breakdown, regeneration, and associated
negative outcomes such as tissue fibrosis and fat accumulation.
This research will provide a sound basis for understanding
how inflammatory dysregulation may contribute toward the
misdirected differentiation of stem cells, progenitors and other
more committed cells located at the wound site in conditions
such as HO. We shall now consider the contribution of
several prominent cytokines identified following trauma on
skeletal muscle regeneration, and how these cytokines may
negatively affect the balance between tissue repair and HO
(Figure 2).
TGF-β contributes to muscle fibrosis and healing following
injury. This cytokine is largely produced by infiltrating
leukocytes, such as neutrophils and macrophages, during the
regenerative stage of muscle repair (Figure 1). The effects
of TGF-β during embryonic myogenesis are complex and
thought to coordinate events leading to myoblast fusion,
thereby preventing premature myotube formation (Kollias and
McDermott, 2008). The addition of exogenous TGF-β isoforms
in vitro has been shown to reduce the fusion efficiency of C2C12
myoblasts, leading to a reduction in the total number ofmyotubes
formed (Schabort et al., 2011). Data suggests that this cytokine
is likely to exert a concentration-dependent effect when added
exogenously to tissue engineered skeletal muscle, with studies
showing that 2 ng/ml promotes greater functional and structural
characteristics when compared with lower concentrations (Weist
et al., 2013). However, tissue engineered models generated in
the presence of TGF-β1 in concentrations greater than 2 ng/ml
fail to form functional myotubes, suggesting an inhibition of
differentiation and maturation. These observations are likely
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attributed to the specific intra-cellular milieu that largely
contributes to the outcome of TGF-β1 in skeletal muscle.
Together the data suggest that high levels of TGF-β observed
following muscle injury may reduce the total number of
terminally differentiated cells, instead causing them to undergo
an extended proliferative phase, which is likely required to
ensure an adequate number of cells is present at the site of
tissue damage before any irreversible myogenic commitment is
made.
TGFβ also has a role in directing the expression of scleraxis
(Scx) in skeletal muscle fibroblasts, promoting proliferation
and collagen type-I synthesis important for tissue repair. This
transcription factor is expressed in fibroblasts during embryonic
development and recent data suggests that the expression of
Scx may have an association with ectopic ossification during
tendonopathy (Omachi et al., 2015). However, at present the
role of Scx+ cells during skeletal muscle ossification remains
largely unknown. In addition to the role of TGFβ during
skeletal muscle regeneration it has been found to promote
activation of the osteogenic transcriptional regulator Runx2 in
C2C12 myoblast cultures (Lee et al., 2000). Significantly, the
addition of TGF-β1 in combination with BMP-2 caused potent
HO in vivo, highlighting the possible enhancing properties of
this growth factor on BMP-induced ossification (Tachi et al.,
2011). Furthermore, the addition of TGF-β1 to primary mouse
myoblast cultures has been shown to induce the expression
of muscle progenitor cell markers, Pax7 and Sca-1 (Mu and
Li, 2011). Together, this data suggests that TGF-β1 is able
to induce myoblast reversion to a progenitor-like cell capable
of osteogenic differentiation in the presence of osteoinductive
factors such as BMP-2. However, we would like to point out
that the indirect osteoinductive effects of TGF-β1 are not
solely confined to skeletal muscle cells. This cytokine has also
been shown to promote endothelial cell trans-differentiation;
a process implicated in ectopic bone formation resulting from
conditions such as HO and arteriosclerosis (Medici et al., 2010).
Together these data highlight TGFβs capacity to contribute
to HO either by facilitating osteogenic differentiation in the
presence of osteoinductive factors such as BMP-2, or by
promoting the transdifferentiation of committed cells to an
osteogenic phenotype. Therapies controlling TGFβ levels at the
wound site may have considerable value as HO prophylactics,
and this may in part explain the efficacy of current NSAID
administration.
IGF-1 is released by M2 macrophages that contribute to
muscle fiber reconstruction during the anti-inflammatory phase
of tissue regeneration (Philippou et al., 2007). Therapeutic
application of IGF-1 in preclinical trials has shown increased
muscle mass, reduced degeneration and increased satellite cell
proliferation (Song et al., 2013). The endogenous production of
skeletal muscle IGF-1 is also well documented and plays a role
at autocrine and paracrine levels (Adams, 2002). Furthermore,
the level of mRNA transcripts specific to IGF-1, are dependent
on the extent of original injury intensity (Matheny et al., 2017).
IGF-1 signaling has been implicated in many different aspects
of muscle regeneration, contributing to protein synthesis and
hypertrophy (PI3K/AKT/mTOR pathway) and cell proliferation
and mitogenesis (RAS/Raf/MEK pathway) (Song et al., 2013).
The production of this anabolic hormone has also been shown
to promote the proliferation and migration of satellite cells and
inflammatory cells to sites of muscle damage, and blocking
either IGF-1 or the IGF-1 receptor in vivo leads to grossly
underdeveloped skeletal muscle, although the IGF-1 receptor
has been shown to be dispensable for post-natal skeletal muscle
hypertrophy (Spangenburg et al., 2008). The action of IGF-1 in
skeletal muscle is further complicated by a number of IGF-1
binding proteins (IGFBPs) found within the extracellular fluid
and function as a depot for the controlled release of IGF-1 (Song
et al., 2013); as well as alternative splice variants (Phillippou
and Barton, 2014), whereby distinct E-peptides are produced
following exercise or injury (Tonkin et al., 2015). Specifically in
muscle, three C-terminus peptides are produced from alternative
splicing; Ea, Eb, and Ec (also known as MGF in humans;
Velloso and Harridge, 2010). These splice-variants contribute to
divergent responses, whereby the translated IGF-1ea pro-peptide
contributes to differentiation and MGF stimulates proliferation
and inhibits differentiation (Ates et al., 2007).
The action of this hormone is not solely myogenic, and
there is evidence to suggest that persistently elevated levels of
IGF-1 following muscle damage may also be associated with
osteochondrogenic differentiation, potentially from the paracrine
action of skeletal muscle-derived IGF-1. Indeed, the contribution
of IGF-1 to skeletogenesis is well known, with IGF-1 signaling
exerting a direct effect on osteoblasts and chondrocytes via an
association with growth hormone during embryogenesis (Ahmed
and Farquharson, 2010). In addition, IGF-1 also modulates the
anabolic effects of parathyroid hormone (PTH), a hormone with
important anabolic and catabolic effects during bone remodeling
(Lombardi et al., 2011). IGF-1 knockouts were shown to lack the
anabolic effects associated with intermittent PTH administration,
such as increased alkaline phosphatase activity and greater
bone mineral density (Bikle et al., 2002). These effects have, at
least in part, implicate IGF-1 signaling in PTH stimulation of
RANKL (Wang et al., 2007a) and ephrin B2/EphB4 stimulation
of osteoclastogenesis, osteoblast proliferation and differentiation
(Matsuo and Otaki, 2012). IGF-1 is particularly important for
longitudinal bone growth and defects attributed to IGF-1 gene
deletion include extreme short stature in humans (Batey et al.,
2014). This hormone also coordinates chondrocyte hypertrophy
through Wnt/β-catenin signaling, which represents a critical
stage during endochondral ossification; subsequently leading to
angiogenesis and remodeling of the cartilaginous matrix to form
bone (Wang et al., 2010). A previous study has implicated IGF-1
in the early ossification of bone marrow explants, which is
significant given that MSCs may be recruited from the bone
marrow to sites of skeletal muscle damage following trauma
(Gurkan et al., 2010). Together, these studies highlight the
important reparative effects of IGF-1 following skeletal muscle
trauma, but also the differential effects that this hormone is
likely exert on cells at different stages of lineage commitment.
Based on this evidence we suggest that the persistence of IGF-
1 in a chronic wound environment could act in conjunction
with osteochondrogenic factors to facilitate the formation ectopic
bone.
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An elevated level of pro-inflammatory cytokines TNF-α and
IL-1β is consistent with previous trauma studies (Pasinetti et al.,
1993; Evans et al., 2012). These cytokines are primarily associated
with the presence of early invading T helper cells and monocytes
recruited to the tissue during the initial stages of muscle repair
(Rigamonti et al., 2014). Production of these cytokines has also
been identified in degenerating and regeneratingmuscle cells, NK
cells, and neutrophils, as well as in endomysial and perimysial
connective tissue (Loell and Lundberg, 2010). TNFα persists
during the initial reparative stages following muscle injury,
facilitating proteolysis and catabolism, and the effects of elevated
levels of pro-inflammatory cytokines such as IL1 and TNFα on
skeletal muscle wasting have been well documented in a number
of inflammatory conditions (Popa et al., 2007). Nevertheless,
it appears that endogenous TNFα plays a significant role in
skeletal muscle regeneration in a physiological capacity (Chen
et al., 2007), while the deleterious effects of this cytokine may
be as a consequence of higher concentrations from a paracrine
source. Current reports concerning the osteoinductive capacity
of these cytokines are mixed. A number of in vitro studies have
documented osteogenic differentiation in the presence of TNF-α
via activation of theNF-KappaB pathway (Hess et al., 2009); while
some in vivo studies state that this cytokine acts to suppress the
osteogenic differentiation of MSCs (Yang et al., 2013). Therefore,
it appears likely that the effects of TNF-α on the osteogenic
differentiation of stem cells is likely to be dependent on its
concentration and association with other inflammatory agents
present in complex biological systems. We would suggest that
any contribution of TNF-α to HO is perhaps most likely to occur
during the chondrogenic phase of differentiation by exerting
an osteoinductive effect on multipotent cells at the wound site.
This prediction is in line with previous studies showing that
the combined presence of pro-inflammatory cytokines TNF-α
and IL-1 can promote endochondral ossification in chondrocytes
through expression of the pro-osteogenic factor BMP-2, as well
as by up-regulating tissue non-specific alkaline phosphatase
activity (Lencel et al., 2001; Fukui et al., 2003). Additionally,
the presence of these cytokines has been linked with the onset
of vascular calcification and the formation of syndesmophytes
(ectopic ossifications where ligaments, tendons and capsules
attach to bone), thereby proving further links between these
factors and ectopic bone formation. Together these reports
suggest that the osteochondrogenic effects of TNF-α and IL-1 are
highly dependent on the particular stage of ectopic ossification,
highlighting that efficient resolution of the pro-inflammatory
stage is likely to be important for preventing the effects of
osteoinductive factors in the presence of local and migratory
progenitor cells.
In addition to IL-1, a number of other interleukins are
up-regulated in wound exudate following physical trauma. Of
these interleukins, IL-3, -4, -6, and -10 are perhaps the most
interesting when one considers muscle regeneration and the
pathology of HO. IL-3 is produced by activated T-lymphocytes
and contributes to the differentiation of haematopoietic stem
cells toward a myeloid lineage. This is significant given that
myeloid hyperplasia is a phenomenon associated with HO but
paradoxical given that IL-3 is a potent inhibitor of osteoblastic
differentiation (Ehrlich et al., 2005). IL-4 is produced by T
helper 2 (Th2) cells during tissue regeneration, and associated
with an increase in the presence of M2 macrophages, which
consequently leads to an increased synthesis of TGF-β and an
indirect association with tissue fibrosis (Tatano et al., 2014).
Together with other T cell cytokines (IL-1 and TNFα) IL-4 is
involved in positively regulating osteoclast maturation through
the NF-κB pathway (Hu et al., 2014). The association between
IL-4 and osteoclast-mediated bone resorption means that this
cytokine is unlikely to contribute toward HO but may instead
have a preventative role. IL-6 is released from skeletal muscle
following contraction (e.g., exercise), and its autocrine effects
on skeletal muscle tissue are equivocal, having been shown to
be important for satellite cell mediated muscle growth (Serrano
et al., 2008) and implicated in muscle atrophy (Haddad et al.,
2005). However, IL-6 is further released by a number of different
inflammatory cells following muscle injury, and appears to be
important for the chemotactic signaling of macrophages, thereby
facilitating muscle regeneration via immune modulation (Zhang
et al., 2013). In addition to its roles during muscle regeneration,
Il-6 has a complex role in bone homeostasis, and exerts different
effects on osteoblasts and osteoclasts depending on their stage
of differentiation (Lieder and Sigurjonsson, 2014). Hence this
cytokine has been documented as having both resorptive and
osteoinductive effects depending on the metabolic state of the
cells involved. Notably, IL-6 induces osteogenic differentiation
in bone marrow stem cell cultures by down-regulating the
expression of Sox2, a transcription factor involved inmaintaining
stem cell multipotency (Yoon et al., 2014). Lastly, IL-6 can
stimulate transcription of the anti-inflammatory cytokine IL-10,
which has a central role in regulating macrophage phenotype,
promoting a switch to M2 macrophages that are required for
normal muscle growth and regeneration (Deng et al., 2012). In
the context of bone development, the presence of IL-10 has been
shown to be important for endochondral ossification via the
stimulation of the BMP signaling pathway (Jung et al., 2013).
Importantly, dysregulation in the BMP signaling pathway is
the primary cause of FOP, a rare genetic form of HO (Kaplan
et al., 2004). Furthermore, there is also substantial evidence to
implicate BMP signaling in the development of acquired HO. As
such, factors that influence this signaling pathway may represent
potential targets for the future therapies.
A number of other proteins with defined roles in muscle
regeneration have been shown to contribute to osteogenic
differentiation. Amphiregulin, a growth factor secreted by
T regulatory (Treg) cells that have been shown to rapidly
accumulate within areas of skeletal muscle injury in mice has
been shown to contribute to muscle repair in vivo (Burzyn et al.,
2013). Muscle repair also features two heparin-binding growth
factors, HGF and FGF, which are sequestered and presented
at the ECM to facilitate regeneration. HGF has recently been
shown to be derived from paracrine sources such as activated M2
macrophages but can also be secreted by proliferating satellite
cells (Sakaguchi et al., 2014). HGF plays a fundamental role
during the early stages of muscle regeneration by stimulating
the migration and activation of satellite cells. It has been shown
to be released when these cells are mechanically stretched in
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vitro (Tatsumi et al., 2001) and can be observed by in vivo time
course experiments at 4–6 days following crush injury (Do et al.,
2012). Up-regulation of HGF following mechanical stretch or
injury may be related to recent discovery that implicates this
growth factor in inflammatory resolution, which appears to be
linked with inhibition of the inflammatory master regulator,
NF-κB/p65 (Proto et al., 2015). In addition to its anabolic role
during myogenesis, it has also been demonstrated that binding
of HGF to the c-met receptor can act to inhibit the expression of
myogenic transcription factors MyoD and myogenin (Anderson,
2016). Recent work has suggested a novel role for HGF in
muscle regeneration, whereby selective silencing of muscle-
specific HGF contributes to degeneration of the diaphragm in
the mdx;p65± model of improved dystrophic phenotype (Proto
et al., 2015). Such a response may be as a consequence of the anti-
inflammatory effect of HGF. However further work is required to
confirm this hypothesis.
Previous studies have also shown that HGF has a
concentration-dependent effect on the osteogenic differentiation
of MSCs (Aenlle et al., 2014). Consequently, there is a need
to understand the potential osteoinductive effects of HGF on
resident stem/progenitor cells as well asmigrating stem cells from
the bone marrow. In addition to HGF, several members of the
FGF family of growth factors are released from the cytosol during
muscle breakdown and repair. Of this family of proteins, FGF-2
has been shown to have a role in the osteogenic differentiation
of MSCs (Miraoui et al., 2009). The action of FGF-2 during
muscle repair is not well documented, but appears to promote
satellite cell proliferation while repressing myogenic lineage
commitment. Therefore, much like physiologically elevated
concentrations of TGF-β, FGF-2 may facilitate the production
of a pool of resident progenitors that can be osteogenically
induced in a post-trauma environment (Jump et al., 2008). Most
significantly, it has been proposed that the mechanically induced
release of FGF-2 following muscle contraction and plasma
membrane disruption represents a potential mechanisms linking
the coupled physiological processes of muscle regeneration and
bone formation (Hamrick, 2012). Interferon gamma (IFNγ) is
another early cytokine frequently identified within the wound
eﬄuents of trauma patients. This factor is released by myoblasts
and immunological cell types such as macrophages, T cells and
natural killer cells in response to tissue damage. IFNγ mediates
the hypercatabolic state of multiple cell types following trauma
(Madihally et al., 2002), and is one of the principal initiators
of M1 macrophage polarization. Furthermore, this cytokine
has been identified as an inhibitor of ossification and blocking
its expression has been shown to alter myoblast proliferation
and fusion (Cheng et al., 2008). The antifibrotic effect of this
cytokine is already being exploited to limit the formation of
scar tissue following traumas. However, at present the potential
prophylactic effects of IFNγ and other early inflammatory
cytokines have yet to be examined for patients at risk of
developing HO.
In addition to ECM synthesis, efficient muscle repair
also requires coordinated tissue breakdown and remodeling.
This is primarily the role of a family of calcium-dependent
endopeptidases called the matrix metalloproteinases (MMPs)
and their tissue inhibitors (TIMPs), which act to breakdown
collagen and non-collagenous substrates, allowing the
recruitment of myogenic, inflammatory, vascular and fibroblastic
cells to the wound bed. The process of tissue breakdown is
important as it provides a pathway for myoblast and satellite
cell migration and differentiation during muscle repair. The
process of is also important for increasing the bioavailability of
growth factors sequestered within the ECM. MMPs localized
to skeletal muscle during tissue regeneration include MMP-1,
2, 9, and 13, with each likely to have a distinct temporal role
during myoblast differentiation (Zimowska et al., 2008). Indeed,
distinct roles for MMP-2 and MMP-9 in the migration and
differentiation of human skeletal muscle-derived cells have
previously been demonstrated by a member of our group
(Lewis et al., 2000). Importantly, MMPs degrade fibronectin
present in the extracellular matrix to promote myoblast fusion
and muscle repair (Chen and Li, 2009). In addition to their
roles during muscle repair, MMPs are also highly important
for tissue remodeling during endochondral ossification, with
the expression of these endopeptidases linked with osteogenic
transcription factors. For instance MMP-13 transcription is
controlled by Runx2 expression during skeletal embryogenesis
and fracture repair (Jimenez et al., 1999). MMP-1 and -2 also
have important roles during endochondral bone formation,
with allelic mutations in these proteins leading to osteolysis
and arthritis-like symptoms (Temtamy et al., 2012). However,
with the exception of MMP-9, the roles of these proteins during
HO remain largely unknown. MMP-9 is co-localized within
polymorphonuclear inflammatory cells such as leucocytes
and macrophages that migrate to the site of injury during the
inflammatory response. Interestingly, this protein is associated
with osteoinductive factors involved in HO, with a study
demonstrating MMP-9 co-localization at nerves and vessels
as early as 48 h after BMP-treatment. As such it has been
hypothesized that this matrixin may represent a diagnostic
marker valuable for predicting the onset of HO (Rodenberg et al.,
2011).
ADIPOGENESIS
Adipocytes are not common within skeletal muscle, and are
confined to the connective tissue septa of healthy individuals. The
accumulation of fat at sites of muscle fibrosis (fatty degeneration)
increases subsequent tissue dysfunction and is linked with failed
muscle regeneration. The formation of fat following tissue
regeneration also leads to a subsequent decrease in local oxygen
tension, which facilitates chondrogenesis and possibly leads to
the formation of endochondral bone (Olmsted-Davis et al., 2007).
Originally it was proposed that trauma led to dysregulation of
the fate switch governing satellite cell differentiation, causing
these cells to differentiate to an adipogenic lineage (Shefer
et al., 2004). However, subsequent studies revealed that the
formation of ectopic fat was actually most significant when
muscle regeneration was impaired, such as when the satellite cell
population is reduced (Sambasivan et al., 2011). More recent
evidence points to the fact that the adipogenic population is
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FIGURE 3 | Potential mechanisms leading to brown adipose tissue formation within regenerating skeletal muscle. The presence of brown fat following
muscle injury establishes a hypoxic gradient that contributes toward a number of processes known to precede HO, including neovascularization and chondrogenesis.
However, the origin of this tissue remains unknown, possibly being derived from a number of local progenitors (e.g., satellite cells and type-1 pericytes), migratory cell
types (bone marrow MSCs), resident fibroblasts or committed cells shown to undergo transdifferentiation in response to cytokines such as TGF-β. Skeletal muscle
satellite cells and myoblasts are not thought to have a significant contribution to the formation of brown fat, with a greater accumulation demonstrated when resident
satellite cells are reduced.
likely to be of fibroblast rather than myogenic origin, with the
intramuscular injection BMP-2 expressing fibroblasts causing
an accumulation of brown adipocytes after just 24 h (Olmsted-
Davis et al., 2007). However, in addition to fibroblasts, numerous
other endogenous and migratory cell types have shown a
capacity for adipogenesis (Davies et al., 2015) (Figure 3). For
instance MSCs, hypothesized to migrate from the bone marrow
following trauma (Pignolo and Shore, 2013), have a well-defined
adipogenic capacity. This is also true of multipotent progenitors
localized within skeletal muscle (Lau et al., 2015). Significantly,
a population of Sca-1+/CD34+ fibro/adipogenic progenitors
(FAP) have been identified in murine skeletal muscle. These
FAP cells are non-myogenic, but proliferate in response to tissue
damage, enhancing the rate of proliferation of other myogenic
progenitors and facilitating muscle repair. Subsequently, human
counterparts have been identified that can be identified by their
CD15+/PDGFRα+/CD56− phenotype (Arrighi et al., 2015).
However, since these cells give rise to white adipose tissue
rather than brown it is unlikely that they represent the primary
contributors to HO. Furthermore, questions regarding the exact
relationship between these cells and skeletal muscle fibroblasts
remain unanswered owing restrictions in immunophenotyping.
However, it should be noted that in the absence of brown fat,
white adipocytes have been shown to convert to fat-oxidizing
cells, thereby providing a compensatory mechanism for reducing
local oxygen tension (Olmsted-Davis et al., 2007). Therefore, the
contribution of FAP cells to HO cannot altogether be ruled out.
Skeletal muscle adipogenesis may not be solely confined to
cells of mesenchymal origin. Cells of the vasculature may also
influence the formation of ectopic adipose tissue at sites of
trauma. For instance multipotent cells residing in the vasculature
called pericytes have been shown contribute to skeletal muscle
adipogenesis. Pericytes can be split into two subpopulations,
each with a distinct contribution to skeletal muscle regeneration.
Transplant studies have shown that type-2 pericytes have
a positive contribution to muscle regeneration, while type-
1 pericytes are associated with fatty degeneration (Birbrair
et al., 2013). However, the vascular contribution to skeletal
muscle adipogenesis may not solely be restricted to multipotent
pericytes. Pioneering new research has shown that endothelial
cells in adipose tissue capillaries can give rise to both white
and brown fat (Tran et al., 2012). This is significant given that
a number of studies have identified endothelial-mesenchymal
transition (EndMT) as a possible mechanism, at least in part, for
the formation of HO (Medici and Olsen, 2012). Based on the
wealth of evidence linking aberrant muscle regeneration, fatty
degeneration and HO, we propose that blocking adipogenesis
may represent an effective way of preventing HO, and it has
been highlighted that the use of BMP antagonists may be
one way of accomplishing this goal—since BMPs (e.g., BMP-
4) have a central role in regulating adipogenic precursor cell
commitment and differentiation (Gustafson et al., 2015). The
use of BMP antagonists would also likely be useful in limiting
the osteochondrogenic differentiation of cells contributing to
HO, and we shall explore this in more detail later in the
manuscript. Lastly, we would like to end this section by
commenting on the seemingly complex relationship between
skeletal muscle adipogenesis and the hypoxic tissue environment
that is thought to precede HO. Previous studies have shown that
hyperglycaemic oxidative stress is able to induce muscle stem
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cell transdifferentiation, and as such the hypoxic environment
following blast trauma is likely to, at least in part, result as
a consequence of fatty degeneration during skeletal muscle
regeneration (Natalicchio et al., 2011). We shall now explore the
association between tissue hypoxia and HO in more detail.
TISSUE HYPOXIA
Oxygen tension has an important role during wound healing,
with either hyperbaric oxygen therapy or low-pressure oxygen
therapy routinely used to promote tissue regeneration (Gottrup,
2004). Conversely, low oxygen tension is found to negatively
affect tissue regeneration, and the link between local tissue
hypoxia and the development of HO is relatively well
established (Kan and Kessler, 2011). Low oxygen tension
leads to the activation of hypoxia-inducible factor (HIF),
a heterodimeric transcription complex that helps coordinate
angiogenesis through the induction of vascular endothelial
growth factor (VEGF) (Zimmermann et al., 2013) (Figure 4).
This process is critical during endochondral bone formation,
and has also been associated with cancer development and
progression (Cao et al., 2009). Additionally, the presence of HIF1
in arteries has been linked with the development of conditions
leading to vascular calcification, such as atherosclerosis (Hao
et al., 2014). HIF1 is also important in directing EndMT
via regulation of TWIST, a transcription factor implicated in
cell determination and differentiation, which is considered an
important factor underlying cancer metastasis (Yang and Wu,
2008). This is significant given that EndMT has been proposed
as a possible mechanism contributing to HO. Incidentally, given
that HO can be defined as pathological ad uncontrolled bone
formation at atypical sites, drawing parallels between ectopic
bone formation and tumor growthmay not be wholly unjustified.
HIF1 has also been shown to enhance the expression of MMPs,
which breakdown the surrounding matrix, potentially allowing
the migration and invasion of a number of inflammatory,
vascular and myogenic cell types during muscle repair (Gilkes
and Semenza, 2013). Within skeletal muscle HIF contributes to
myoblast proliferation and the growth of regenerating myofibres
(Scheerer et al., 2013). In this tissue anaerobic ATP and
lactate production are increased through glycolysis, and pyruvate
dehydrogenase kinase enzymes are upregulated limiting pyruvate
decarboxylation and maintaining cellular energy homeostasis
at low oxygen concentrations. Energy metabolism has also
been shown to be altered through the effects of HIF1α on
glucose transport via Glut1 and Glut3 (Mobasheri et al., 2005).
Significantly, delivery of echinomycin, a HIF1α inhibitor, in a
mouse model was able to significantly reduce the volume of
ectopic bone formed following Achilles tenotomy (Zimmermann
et al., 2013). Moreover, the HIF1α pathway is important
for coupling angiogenesis with osteogenesis during skeletal
development (Wang et al., 2007b). An important study that
relates HIF to the development of HO has identified that
this factor acts as a regulator of BMP2 induced endochondral
ossification in fetal limb cultures (Zhou et al., 2015). Additionally,
HIF-transduced bone marrow stem cells have also been shown
to undergo osteogenic differentiation (Zou et al., 2011). Based
on these findings it is likely that reduced oxygen tension at
the site of trauma and the accompanying transcription of HIF
have a direct contribution to the development of HO. However,
blocking or down-regulating HIF is likely to have a negative effect
on neo-angiogenesis and tissue regeneration. Since this process
represents an essential stage in the regeneration of injured tissues
the dose and timing of such a therapy is likely to be critical when
treating victims of severe trauma.
ANGIOGENESIS
The formation of new blood vessels is essential for the
regeneration of damaged muscle. However, angiogenesis is also
tightly linked with endochondral ossification, and represents
an important stage during both embryonic skeletogenesis and
FIGURE 4 | The effects of oxygen tension on tissue repair and HO. The presence of tissue hypoxia is frequently described at sites of trauma and has been
linked with HO. Under normoxic conditions HIF1α is polyubiquitinated and proteasomally degraded. Under hypoxic conditions HIF1α localizes with HIF1β to form a
transcription complex that promotes the synthesis of target genes related to angiogenesis, endothelial-mesenchymal transition (EndMT), tissue breakdown and
remodeling, energy metabolism, and chondrogenesis.
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fracture callus formation. In a post-trauma environment, neo-
angiogenesis in the presence of osteogenic progenitors is
likely to facilitate the delivery of cells and soluble factors
that contribute to HO. The re-vascularization of damaged
tissue is a complex process that relies on the presence of
a myriad of different angiogenic factors that are secreted
by endogenous myoblasts and muscle progenitors, as well as
endothelial cells, pericytes, leukocytes and possibly multipotent
cells derived from the circulation. Furthermore, angiogenesis
is tightly coupled with myogenesis and has been hypothesized
to result from a crosstalk between endothelial cells and
resident satellite cells that are located within close proximity
to capillaries. Crosstalk between these cells is thought to
involve the secretion of soluble factors such as IGF-1, FGF,
HGF, and VEGF (Christov et al., 2007). Of these factors,
the role of VEGF in tissue revascularization is perhaps best
understood. VEGF is expressed by hypertrophic chondrocytes
before cartilage becomes vascularized and remodeled to form
bone, and also by brown adipocytes found within damaged
tissues that go on to develop HO (Ueno et al., 2004).
Any link between VEGF and the progression of HO further
implicates local or migratory endothelial cells in the process
of osteochondrogenic differentiation, which is consistent with
histological examination of ectopic bone nodules formed in the
soft tissues of patients with ossification (Lounev et al., 2009).
These histological examinations noted increased vascularity
in ectopic bone, which may be a result of an increased
concentration of local VEGF, together with an increase in the
proportion of perivascular lymphocytes (Gannon et al., 1997).
Increased vascularization during HO development has also been
highlighted by Peterson et al. (2014), where it was shown
that mice with burn injuries displayed enhanced vascularization
within implanted BMP2 transfected ADSC/collagen ossicles
(Peterson et al., 2014). Considerable neo-vascularization within
ectopic bone suggests the involvement of endothelial cells or
migratory mesenchymal stem-like cells with the capacity to form
vascular networks. Furthermore, these lymphocytic infiltrates
have been shown to overexpress members of the BMP family
that are found in high concentration within FOP lesions, and
have been shown to induce ectopic bone formation when
injected intramuscularly (Leblanc et al., 2011; Grenier et al.,
2013).
In addition to the contribution of VEGF during tissue
vascularization, platelets that aggregate at the site of local
blood vessels also have an important role in directing neo-
angiogenesis. The aggregation of platelets at the site of tissue
damage initially acts to limit blood loss. However, platelets
also have an important role in driving tissue vascularization,
with activated platelets releasing PDGF, TGF-β1, VEGF, and
bFGF upon degranulation (Torreggiani et al., 2014). The roles
of TGF-β1, VEGF, and bFGF have been previously described
and we shall not comment on these further. Instead we shall
focus our attention in the role of PDGF, which can exist in
any of three isoforms: PDGF-AA, -AB, and -BB. Of these
three isoforms, only PDGF-BB has been shown to have a
significant role during muscle regeneration. As stated, PDGF-
BB is initially released by activated platelets during the body’s
initial response to tissue damage. It is subsequently released
by macrophages that enter the tissue via the circulation and
promote the migration of muscle precursor cells (Li et al.,
2010). Although the exact contribution of PDGF during HO
is unknown, recent studies are beginning to outline a clear
relationship between PDGF and extra-skeletal ossification. For
instance, the addition of platelet-derived exosomes to MSC
cultures has been shown to trigger osteogenic differentiation in
vitro (Torreggiani et al., 2014). Furthermore, a valuable study
looking at therapeutic mechanisms for the prevention of HO has
identified that the administration of imatinib, a PDGF antagonist,
significantly reduced the volume of ectopic bone formed in an
Achilles tenotomy model (Werner et al., 2013). As a whole these
data suggest that exerting control over the angiogenic response
following trauma may represent an effective intervention for
reducing HO after trauma, and that PDGF and VEGF represent
potential therapeutic targets.
ENDOCHONDRAL OSSIFICATION
Ectopic bone formed as a result of HO is frequently described
as endochondral (Kan and Kessler, 2011). There is currently
a wealth of evidence implicating BMP signaling as a primary
mechanism governing the formation of acquired HO. However,
the effects of these proteins are not solely confined to
osteogenic differentiation, but have also been linked to the
physiological regulation of muscle mass (Winbanks et al., 2013).
In fact this family of multifunctional growth factors is crucial
during embryonic skeletal development, and genetic mutations
resulting in alterations in BMP expression can have serious
consequences. One such example being FOP, the rare genetic
form of HO resulting from an activating missense heterozygous
mutation in the ACVR1 gene that encodes the BMP type-I
receptor ACVR1/ALK2 (Kaplan et al., 2010). At present our
understanding of the mechanisms governing acquired HO are
less advanced than for FOP. However, a number of studies have
identified that, although these two conditions are pathologically
distinct, BMPs play an important role in both forms of the
condition.
Of the 20 BMPs currently characterized, previous studies
have shown that BMP-2, -6, -7 and -9 can promote osteogenic
differentiation in skeletal muscle myoblasts both in vitro and in
vivo, when transplanted into the quadriceps of nude mice (Liu
et al., 2009). Furthermore, BMP-4 expressing muscle-derived
stem cells undergo osteogenic differentiation in vivo (Wright
et al., 2002). Administration of commercially available BMP-2
and BMP-7 has been shown to lead to HO at the site of joints and
may provide some rationale for the formation of ectopic bone
following surgeries such as hip arthroplasty (Axelrad et al., 2008;
Chen et al., 2010). In fact, studies examining the effects of BMP-
2 on myoblasts and Tie2+ PDGFRα+ Sca-1+ muscle-derived
progenitor cells have shown that the presence of BMPs at the site
of muscle damage is likely to inhibit myogenesis and promote
osteogenic differentiation (Katagiri et al., 1994; Wosczyna et al.,
2012). Together these studies lead us to conclude that ectopic
bone formed following trauma may result, in part, from the
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action of BMPs on endogenous muscle progenitors as well as
more committed skeletal muscle cells. The role of BMP-2 was
perhapsmost convincingly demonstrated in a blocking study that
utilized recombinant human Gremlin, a BMP-2 antagonist, to
reduce calcific tendonopathy, a type of ectopic bone formation
affecting one in five people over the age of fifty (Yeung et al.,
2014).
We would also like to draw attention to the potential
contribution of BMP-2 during neurological HO. This type
of HO is frequently associated with TBI or SCI, which can
similarly lead to ectopic ossification in tissues such as skeletal
muscle (Cipriano et al., 2009). BMP-2 has been linked to the
process of sensory nerve induced inflammation by coordinating
the release of neuro-inflammatory factors substance P and
calcitonin gene-related peptide (CGRP) (Bucelli et al., 2008). The
release of neuro-inflammatory factors initiates the recruitment of
immunological cells, such as platelets, mast cells and neutrophils
to the site of injury and also increases mast cell degranulation
and the release of stem cells with an osteochondrogenic potential
(Salisbury et al., 2011). Together, this combination of factors
is likely to contribute to the misdirected differentiation of
multipotent cells toward and osteochondrogenic phenotype and
we conclude that there is strong evidence to suggest that
BMPs (particularly BMP-2) contribute to HO both directly and
indirectly via the peripheral nervous system.
Hormones have a critical role during embryonic
skeletogenesis and are involved in the conversion of cartilage
to bone during endochondral ossification. Growth hormone
(GH) is known to be an important regulator of endochondral
bone development by promoting cartilage proliferation, with
elevated levels leading to gigantism (Nilsson et al., 2005). This
peptide hormone also stimulates the production of IGF-1
and synergizes with BMP-9 to promote chondrocyte and
osteoblast activity through the JAK-STAT pathway (Huang
et al., 2012). The presence of the hormone-like lipid compound
prostaglandin E2 (PGE2) in the urine may be used as in the
early diagnosis of HO (Ahrengart, 1991). In fact it is thought
that a number of PGs may act as predictors of HO, with
these hormones inducing a cAMP cascade hypothesized to
represent one possible mechanism governing ectopic bone
formation (Bartlett et al., 2006). The relationship between
PGE2 and HO formation has even led researchers to examine
the efficacy of PGE2-blocking agents such as indomethacin
for preventing ectopic bone formation (Schurch et al., 1997).
However, further research into this mechanism is required
before any firm conclusions can be formulated. Thyroid
hormone is another example of a hormone that may have a role
in HO development. This hormone acts on chondrocytes to
promote hypertrophy and alkaline phosphatase activity, which
is critical for cartilage remodeling and ossification during HO
(Ballock and Reddi, 1994). Of particular note is the fact that
pseudohypoparathyroidism, a condition causing resistance to
parathyroid hormone, has been associated with the formation of
ectopic bone (Adachi et al., 2009). Interestingly, this condition
is caused by a maternally inherited mutation in the GNAS gene.
This is of relevance due to the fact that a mutation in GNAS
has been shown to activate hedgehog signaling, which has been
shown to cause cutaneous ossification in conditions such as
progressive osseous heteroplasia (POH), osteoma cutis Albright
hereditary osteodystrophy (AHO) (Adegbite et al., 2008; Elli
et al., 2013; Regard et al., 2013). As such it is important that the
relationship between this hormone and acquired HO is further
examined.
SUMMARY
Acquired HO most frequently occurs as a result of a traumatic
insult, such as a blast injury or burns. The progression of
this pathology is preceded by inflammatory dysregulation,
which in addition to the primary mechanical stimulus, is
considered to represent one of the primary factors preceding
HO. However, at present there is little experimental data
detailing just how the post-trauma inflammatory response can
alter the balance between effective muscle repair and adverse
pathological outcomes such as HO. Current evidence suggests
that there are multiple predisposing factors that include local
tissue hypoxia, the bacterial colonization of wounds and the
action of pro-angiogenic and osteoinductive factors such as
VEGF and BMPs, respectively. All of these stages represent
opportunities for clinical intervention. However, we propose
that earlier interventions will be most effective, reducing
the likelihood of recurrence. We identify that strategies to
better understand the contribution of chronic inflammation,
and particularly the role of macrophage plasticity in chronic
wounds, may be of considerable benefit for the prevention
of ectopic bone formation. Currently, NSAIDs are the most
commonly prescribed HO prophylactics. However, the efficacy
of these anti-inflammatory drugs is limited, suggesting that
the timing of delivery is a significant factor governing a
satisfactory outcome. This provides further evidence to
suggest that the delicate balance between immunosuppressive
down-regulation of the inflammatory response and its
effects on muscle regeneration and HO need to be further
evaluated.
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